Record number:
260
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
Most recent risk assessment (Council of Europe, 2022): Oesophageal, gastric, pancreatic, liver and biliary cancers diagnosed during donor procurement : These tumours are classified as unacceptable risk. Oesophageal, gastric, pancreatic, liver and biliary cancers in the donor history: Treated tumours of these kinds in the donor history are classified as high risk due to their aggressive behaviour. Risk may decrease for early stages after curative therapy, with recurrence-free time > 5 years and with increasing probability of cure, especially in cases of long-term survivors
Time to detection:
--
Alerting signals, symptoms, evidence of occurrence:
Not provided
Demonstration of imputability or root cause:
Evaluated by OPTN/UNOS Disease Transmission Advisory Committee (DTAC) as confirmed transmission. (Transmission confirmed in 1 recipient from 3 donors)
Imputability grade:
3 Definite/Certain/Proven
Groups audience:
Keywords:
Suggest new keywords:
Liver cancer, type not specified
Registry series
Liver transplant
Suggest references:
aaa
Expert comments for publication:
Reported as part of update of UNOS data. Limited information regarding the specific case.